Cited by 246Pluripotent Stem Cells ResearchCell death mechanisms and regulationMesenchymal stem cell research

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Inhibition of pluripotent stem cell-derived teratoma formation by small molecules

Open access

Lee, Mi-Ok, Moon, Sung Hwan, Jeong, Ho-Chang, Yi, Ji-Yeon, Lee, Tae-Hee, Shim, Sung Han, Rhee, Yong-Hee, Lee, Sang-Hun, Oh, Seok-Jeong, Lee, Moo-Yeol, Han, Min-Joon, Cho, Yee Sook, Chung, Hyung-Min, Kim, Kwang-Soo, Cha, Hyuk-Jin·2013·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.1303669110PMC PMC3761568

Open this paper in CoChat — free account

Abstract

The future of safe cell-based therapy rests on overcoming teratoma/tumor formation, in particular when using human pluripotent stem cells (hPSCs), such as human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs). Because the presence of a few remaining undifferentiated hPSCs can cause undesirable teratomas after transplantation, complete removal of these cells with no/minimal damage to differentiated cells is a prerequisite for clinical application of hPSC-based therapy. Having identified a unique hESC signature of pro- and antiapoptotic gene expression profile, we hypothesized that targeting hPSC-specific antiapoptotic factor(s) (i.e., survivin or Bcl10) represents an efficient strategy to selectively eliminate pluripotent cells with teratoma potential. Here we report the successful identification of small molecules that can effectively inhibit these antiapoptotic factors, leading to selective and efficient removal of pluripotent stem cells through apoptotic cell death. In particular, a single treatment of hESC-derived mixed population with chemical inhibitors of survivin (e.g., quercetin or YM155) induced selective and complete cell death of undifferentiated hPSCs. In contrast, differentiated cell types (e.g., dopamine neurons and smooth-muscle cells) derived from hPSCs survived well and maintained their functionality. We found that quercetin-induced selective cell death is caused by mitochondrial accumulation of p53 and is sufficient to prevent…

Integrity signals

Registry

Crossref · 10.1073/pnas.1303669110

Cites

0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
TAp63α induces apoptosis by activating signaling via death receptors and mitochondria
Gressner, O., Schilling, T., Lorenz, K., Schulze Schleithoff, E., Koch, A., Schulze‐Bergkamen, H., Maria Lena, A., Candi, E., Terrinoni, A., Valeria Catani, M., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600708 · Cited by 255
Human Embryonic Stem Cells Have Enhanced Repair of Multiple Forms of DNA Damage
Maynard, S., Swistowska, A. M., Lee, J. W., Liu, Y., Liu, S.-T., Da Cruz, A. B., Rao, M., de Souza-Pinto, N. C., Zeng, X., & Bohr, V. A. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1041 · Cited by 220
p53 regulation by ubiquitin
Brooks, C. L., & Gu, W. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.05.022 · Cited by 186

Show all 4 references

Research works printed but not linked: 63

10.1126/science.282.5391.1145 · DOI
10.1016/j.cell.2007.11.019 · DOI · Paper page
10.1038/nature10761 · DOI
10.1038/nrd2403 · DOI
10.1016/j.cell.2010.10.008 · DOI
10.1101/gad.1689808 · DOI
10.1016/S0065-230X(08)00005-5 · DOI
10.1038/nbt.1554 · DOI
10.1016/j.bmcl.2008.04.048 · DOI
10.1016/j.bmcl.2007.10.024 · DOI
10.4161/auto.4592 · DOI
10.1002/stem.321 · DOI
10.1634/stemcells.21-3-257 · DOI
10.1111/j.1471-4159.2006.03841.x · DOI
10.1038/nbt.1947 · DOI
10.1634/stemcells.2007-0576 · DOI
10.1002/stem.37 · DOI
10.1074/jbc.M610464200 · DOI
10.1158/0008-5472.CAN-09-4238 · DOI
10.1016/j.mrfmmm.2006.06.006 · DOI
10.1016/j.stem.2008.01.002 · DOI
10.1002/jcp.21735 · DOI
10.1016/j.molcel.2012.04.002 · DOI
10.5966/sctm.2012-0066 · DOI
10.1634/stemcells.2007-0401 · DOI
10.1038/nbt.1527 · DOI
10.1038/nm0897-917 · DOI
10.1172/JCI45794 · DOI
10.1038/nature03579 · DOI
10.1074/jbc.M407985200 · DOI
10.1124/jpet.108.148189 · DOI
10.1161/CIRCRESAHA.109.207902 · DOI
10.1016/S1097-2765(03)00050-9 · DOI
10.1093/emboj/20.23.6627 · DOI
10.1038/sj.onc.1210560 · DOI
10.1074/jbc.M300957200 · DOI
10.1091/mbc.e12-10-0771 · DOI
10.1038/nrc2293 · DOI
10.1016/j.canlet.2007.12.004 · DOI
10.1158/1535-7163.MCT-08-0236 · DOI
10.1158/0008-5472.CAN-07-1343 · DOI
10.1016/j.mad.2006.11.007 · DOI
10.1371/journal.pone.0030541 · DOI
10.1016/j.tcb.2009.12.004 · DOI
10.1038/ncb1211 · DOI
10.1038/sj.onc.1205353 · DOI
10.1093/emboj/17.16.4668 · DOI
10.1074/jbc.M800806200 · DOI
K Matsui, A Fine, B Zhu, A Marshak-Rothstein, ST Ju, Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter: Functional analysis in T cell hybridoma. J Immunol 161, 3469–3473 (1998). · DOI
10.1038/ncb1087 · DOI
10.1111/j.1365-2443.2005.00835.x · DOI
CL Perkins, G Fang, CN Kim, KN Bhalla, The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis. Cancer Res 60, 1645–1653 (2000).
10.1038/sj.cdd.4401418 · DOI
10.1016/j.ejphar.2010.09.020 · DOI
10.1016/j.phrs.2010.05.001 · DOI
10.1080/07357900802337191 · DOI
10.1182/blood-2008-05-157198 · DOI
10.1084/jem.20062395 · DOI
10.1002/stem.121 · DOI
10.1111/j.1471-4159.2004.03006.x · DOI
10.1073/pnas.0605757103 · DOI
10.1038/srep00964 · DOI
10.1016/j.stem.2012.11.015 · DOI

Sorted by citations

Items 101–200 of 228

Genomic instability, driver genes and cell selection: Projections from cancer to stem cells
Ben‐David, U. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.08.005 · Cited by 24
Induced Pluripotent Stem Cells for Tissue-Engineered Skeletal Muscles
Zhao, S., Chen, J., Wu, L., Tao, X., Yaqub, N., & Chang, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411520 · Cited by 23
Design by Nature: Emerging Applications of Native Liver Extracellular Matrix for Cholangiocyte Organoid-Based Regenerative Medicine
Willemse, J., van der Laan, L. J. W., de Jonge, J., & Verstegen, M. M. A. (2022) · Bioengineering · doi:10.3390/bioengineering9030110 · Cited by 26
Safe Transplantation Of Pluripotent Stem Cell By Preventing Teratoma Formation
Mohseni, R. (2014) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000212 · Cited by 17
“In 2013, researchers in Korea found that quercetin and YM155-induced selective cell death is enough to inhibit teratoma formation after transplantation of human pluripotent stem cell-derived cells [49].”
Background
Teratoma formation in immunocompetent mice after syngeneic and allogeneic implantation of germline capable mouse embryonic stem cells.
Aldahmash, A., Atteya, M., Elsafadi, M., Al-Nbaheen, M., Al-Mubarak, H., Vishnubalaji, R., Al-Roalle, A. H., Alharbi, S., Manikandan, M., Matthaei, K., et al. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.10.5705 · Cited by 20
Spotting-based differentiation of functional dopaminergic progenitors from human pluripotent stem cells
Kim, J., Jeon, J., Song, B., Lee, N., Ko, S., Cha, Y., Leblanc, P. R., Seo, H., & Kim, K. (2022) · Nature Protocols · doi:10.1038/s41596-021-00673-4 · Cited by 24
Self-citation
A subcutaneous pancreatic islet transplantation platform using a clinically applicable, biodegradable Vicryl mesh scaffold ‐ an experimental study
Komatsu, H., Gonzalez, N., Salgado, M., Cook, C. A., Li, J., Rawson, J., Omori, K., Tai, Y., KANDEEL, F. R., & Mullen, Y. (2020) · Transplant International · doi:10.1111/tri.13607 · Cited by 20
Targeted Elimination of Tumorigenic Human Pluripotent Stem Cells Using Suicide-inducing Virus-like Particles
Rampoldi, A., Crooke, S., Preininger, M., Jha, R., Maxwell, J. T., Ding, L.-M., Spearman, P., Finn, M. G., & Xu, C.-H. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00490 · Cited by 19
‘Above all, do no harm’: safeguarding pluripotent stem cell therapy against iatrogenic tumorigenesis
Malecki, M. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt462 · Cited by 27
“Metformin suppressed Oct4 in stem cells without interfering with the Oct4-independent abilities of these cells to differentiate into tissues [41].”
BackgroundMethodInfluential
Improved safety of induced pluripotent stem cell-derived antigen-presenting cell-based cancer immunotherapy
Mashima, H., Zhang, R., Kobayashi, T., Tsukamoto, H., Liu, T., Iwama, T., Hagiya, Y., Yamamoto, M., Fukushima, S., Okada, S., et al. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.03.002 · Cited by 23
Selective Elimination of Culture-Adapted Human Embryonic Stem Cells with BH3 Mimetics
Cho, S.-J., Kim, K.-T., Jeong, H.-C., Park, J.-C., Kwon, O.-S., Song, Y.-H., Shin, J.-G., Kang, S., Kim, W., Shin, H., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.09.002 · Cited by 18
“(Avery et al., 2013; Garcia et al., 2016; Lee et al., 2013), would effectively ablate YM155R hESCs based on their gene signatures and theCTRPdataset.”
BackgroundMethodInfluentialSelf-citation
Atorvastatin Inhibits the HIF1α-PPAR Axis, Which Is Essential for Maintaining the Function of Human Induced Pluripotent Stem Cells
Nakashima, Y., Miyagi‐Shiohira, C., Noguchi, H., & Ōmasa, T. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.06.005 · Cited by 24
“26 No 7 July 2018 tency; elimination using cytotoxic antibodies;(68,69) genetic manipulation of potential tumor progression genes in hPSCs;(70,71) insertion of genes to induce cell death after a specific signal, identification of improved ways to separate hPSCs from differentiated cells in culture; synthesis of peptid…”
Background
Photodynamic Approach for Teratoma-Free Pluripotent Stem Cell Therapy Using CDy1 and Visible Light
Cho, S.-J., Kim, S., Park, S.-J., Song, N., Kwon, H., Kang, N., Moon, S., Chang, Y., & Cha, H. (2016) · ACS Central Science · doi:10.1021/acscentsci.6b00099 · Cited by 21
Self-citation
Enhancing genome editing in hPSCs through dual inhibition of DNA damage response and repair pathways
Park, J.-C., Kim, Y.-J., Hwang, G., Kang, C. Y., Bae, S., & Cha, H. (2024) · Nature Communications · doi:10.1038/s41467-024-48111-9 · Cited by 18
“They are highly sensitive to DNA damage triggered by p53-dependent mitochondrial cell death 31,32 , and their DNA damage repair pathways are very active 33 .”
Self-citation
Inducible caspase-9 suicide gene under control of endogenous oct4 to safeguard mouse and human pluripotent stem cell therapy
Liu, Y., Yang, Y., Suo, Y., Li, C., Chen, M., Zheng, S., Li, H., Tang, C., Fan, N., Lan, T., et al. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.01.014 · Cited by 22
“24 March This is an open access article under the CC BY-NC-ND license (http Efforts have been made to reduce tumorigenic risks, including sorting out undifferentiated cells with antibodies that target surface-displayed biomarkers,(4) killing undifferentiated cells with oncolytic virus,(5) or using chemical inhibitors.…”
Background
Natural Killer Cells Prevent the Formation of Teratomas Derived From Human Induced Pluripotent Stem Cells
Benabdallah, B., Désaulniers-Langevin, C., Colas, C., Li, Y.-Y., Rousseau, G., Guimond, J., Haddad, É., & Beauséjour, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02580 · Cited by 17
“To prevent the formation of teratomas, small molecules able to selectively and efficiently kill pluripotent cell by inhibiting antiapoptotic factors were developed (2, 3).”
Background
Preclinical Development of Cell-Based Products: a European Regulatory Science Perspective
McBlane, J. W., Phul, P., & Sharpe, M. E. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2437-y · Cited by 25
Tumorigenic and Differentiation Potentials of Embryonic Stem Cells Depend on TGFβFamily Signaling: Lessons from Teratocarcinoma Cells Stimulated to Differentiate with Retinoic Acid
Гордеева, О. Ф., & Khaydukov, S. (2017) · Stem Cells International · doi:10.1155/2017/7284872 · Cited by 16
Scalable bioreactor-based suspension approach to generate stem cell-derived islets from healthy donor-derived iPSCs
Verhoeff, K., Cuesta-Gomez, N., Maghera, J., Dadheech, N., Pawlick, R., Smith, N., O’Gorman, D., Razavy, H., Marfil-Garza, B., Young, L. G., et al. (2025) · Transplantation · doi:10.1097/tp.0000000000005108 · Cited by 16
The Buccal Fat Pad: A Unique Human Anatomical Structure and Rich and Easily Accessible Source of Mesenchymal Stem Cells for Tissue Repair
Favero, G., van Noorden, C. V., & Rezzani, R. (2024) · Bioengineering · doi:10.3390/bioengineering11100968 · Cited by 16
“However, the modulation of buccal fat pad stem cell differentiation into osteoblasts was difficult, and it is fundamental to remove the residual pluripotent stem cells with teratoma potential before clinical application [48,52].”
Background
Pluripotent stem cell-based cardiac regenerative therapy for heart failure
Soma, Y., Tani, H., Morita-Umei, Y., Kishino, Y., Fukuda, K., & Tohyama, S. (2024) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2023.12.001 · Cited by 17
Label-Free and High-Throughput Removal of Residual Undifferentiated Cells From iPSC-Derived Spinal Cord Progenitor Cells
Nguyen, T., Chooi, W. H., Jeon, H., Chen, J., Roxby, D., Tan, J., Lee, C., Ng, S.-Y., Han, J., & Chew, S. Y. (2023) · bioRxiv · doi:10.1093/stcltm/szae002 · Cited by 16
“17,18 In general, these methods rely heavily on cell-surface markers, which lack sufficient specificity for pluripotent cells.”
Elimination of Teratogenic Human Induced Pluripotent Stem Cells by Bee Venom via Calcium-Calpain Pathway
Kim, A., Lee, S., Kim, B., & Chung, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093265 · Cited by 15
Self-citation
External Beam Radiation Therapy for the Treatment of Human Pluripotent Stem Cell-Derived Teratomas
Lee, A., Tang, C., Hong, W.-X., Park, S., Bazalova, M., Nelson, G., Sanchez-Freire, V., Bakerman, I., Zhang, W. Y., Neofytou, E. A., et al. (2017) · Stem Cells · doi:10.1002/stem.2653 · Cited by 16
Gene editing with ‘pencil’ rather than ‘scissors’ in human pluripotent stem cells
Park, J.-C., Park, M. J., Lee, S.-Y., Kim, D., Kim, K.-T., Jang, H., & Cha, H. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03394-5 · Cited by 17
“Furthermore, elevated expression of proapoptotic factors [38] as well as prompt translocation of active BAX, a pro-apoptotic member of BCL2 family, to mitochondria [49] accounts for the high susceptibility to DNA damage in hPSCs [50].”
BackgroundInfluentialSelf-citation
MutSα and MutSβ as size-dependent cellular determinants for prime editing in human embryonic stem cells
Park, J.-C., Kim, Y.-J., Han, J. H., Kim, D., Park, M. J., Kim, J., Jang, H., Bae, S., & Cha, H. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.05.015 · Cited by 17
Self-citation
Conductive hybrid matrigel layer to enhance electrochemical signals of human embryonic stem cells
Jeong, H., Choo, S.-S., Kim, K.-T., Hong, K., Moon, S., Cha, H., & Kim, T. P. (2016) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2016.11.045 · Cited by 19
Self-citation
Unlocking the Pragmatic Potential of Regenerative Therapies in Heart Failure with Next-Generation Treatments
Kishino, Y., & Fukuda, K. (2023) · Biomedicines · doi:10.3390/biomedicines11030915 · Cited by 14
“For example, survivin is an anti-apoptotic factor specific to hPSCs, and chemical inhibitors of this factor, such as quercetin or YM155, have been reported to promote cell death in undifferentiated hPSCs, but not differentiated cells [89].”
Background
High expression of uracil DNA glycosylase determines C to T substitution in human pluripotent stem cells
Park, J.-C., Jang, H., Kim, J., Han, J. H., Jung, Y., Kim, K.-T., Bae, S., & Cha, H. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.11.023 · Cited by 16
Self-citation
Hepatic population derived from human pluripotent stem cells is effectively increased by selective removal of undifferentiated stem cells using YM155
Kang, S. J., Park, Y.-I., Hwang, S., Yi, H., Tham, N. T. T., Ku, H., Song, J., & Kang, H. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0517-2 · Cited by 15
“Of these small molecules, YM155 in particular triggers apoptosis of USCs but not that of their differentiated derivatives [18].”
BackgroundInfluential
WNT/β-Catenin signaling pathway regulates non-tumorigenesis of human embryonic stem cells co-cultured with human umbilical cord mesenchymal stem cells
Chang, Y., Chu, T., & Ding, D. (2017) · Scientific Reports · doi:10.1038/srep41913 · Cited by 15
Stem Cell-Based Therapies for Polyglutamine Diseases
Mendonça, L. S., Onofre, I., Miranda, C. O., Perfeito, R., Nóbrega, C., & de Almeida, L. P. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-71779-1_21 · Cited by 15
TPX2 prompts mitotic survival via the induction of BCL2L1 through YAP1 protein stabilization in human embryonic stem cells
Kim, Y., Go, Y., Jeong, H.-C., Kwon, E.-J., Kim, S., Cheong, H., Kim, W., Shin, H., Lee, H., & Cha, H.-J. (2023) · Experimental and Molecular Medicine · doi:10.1038/s12276-022-00907-9 · Cited by 13
Self-citation
Clinical considerations in Parkinson’s disease cell therapy
Xue, J., Wu, Y., Bao, Y., Zhao, M., Li, F., Sun, J., Sun, Y., Wang, J., Chen, L., Mao, Y. Q., et al. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101792 · Cited by 16
The Present State and Future Perspectives of Cardiac Regenerative Therapy Using Human Pluripotent Stem Cells
Soma, Y., Morita, Y., Kishino, Y., Kanazawa, H., Fukuda, K., & Tohyama, S. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.774389 · Cited by 13
“differentiated cells Inhibitors of survivin (19) Inhibition of hPSC-specific antiapoptotic factor”
Background
Cell-Based Therapeutic Approaches for Cystic Fibrosis
Duchesneau, P., Waddell, T. K., & Karoubi, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155219 · Cited by 14
Structure-Activity Relationship Analysis of YM155 for Inducing Selective Cell Death of Human Pluripotent Stem Cells
Go, Y.-H., Lim, C., Jeong, H., Kwon, O.-S., Chung, S.-K., Lee, H., Kim, W., Suh, Y., Son, W. S., Lee, M., et al. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00298 · Cited by 15
“, 2007), which is highly expressed in many cancer cell types, as well as hPSCs (Lee et al., 2013).”
BackgroundInfluentialSelf-citation
Emerging innovation towards safety in the clinical application of ESCs and iPSCs
Masuda, S., Miyagawa, S., Fukushima, S., Sougawa, N., Ito, E., Takeda, M., Saito, A., & Sawa, Y. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.9-c1 · Cited by 13
Hurdles for the Wide Implementation of Photoimmunotherapy
Matsuoka, K., Sato, M., & Sato, K. (2021) · Immunotherapy · doi:10.2217/imt-2021-0241 · Cited by 12
Overexpression of Na+/H+ exchanger 1 specifically induces cell death in human iPS cells via sustained activation of the Rho kinase ROCK
Wakabayashi, S., Morihara, H., Yokoe, S., Nakagawa, T., Moriwaki, K., Tomoda, K., & Asahi, M. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010329 · Cited by 12
“Another serious problem in the clinical field was how to eliminate the undifferentiated iPSCs remaining after differentiation, which have the risk of teratoma formation (7).”
Background
A Synthetic Hybrid Molecule for the Selective Removal of Human Pluripotent Stem Cells from Cell Mixtures
Mao, D., Ando, S., Sato, S., Qin, Y., Hirata, N., Katsuda, Y., Kawase, E., Kuo, T., Minami, I., Shiba, Y., et al. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201610284 · Cited by 13
Quantum oscillations as the tool for study of new functional materials (Review Article)
Gusynin, V., Loktev, V., Luk'yanchuk, I., Sharapov, S., & Varlamov, A. (2014) · Low Temperature Physics · doi:10.1063/1.4869583 · Cited by 12
Treating iPSC-Derived β Cells with an Anti-CD30 Antibody–Drug Conjugate Eliminates the Risk of Teratoma Development upon Transplantation
Pellegrini, S., Zamarian, V., Landi, E., Cospito, A., Lombardo, M. T., Manenti, F., Citro, A., Lena, M. S., Piemonti, L., & Sordi, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179699 · Cited by 14
“Regarding negative selection, more than one strategy has been suggested: the insertion of suicide genes through gene-editing strategies [23], the use of chemical inhibitors [24,25] and the use of selective killing by using antibodies [26,27].”
Background
Induced Pluripotent Stem Cell-Derived T Cells for Cancer Immunotherapy
Patel, S. J., Yamauchi, T., & Ito, F. (2019) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2019.02.005 · Cited by 16
Mesenchymal Stem Cells: Potential Role in the Treatment of Osteochondral Lesions of the Ankle
Tribe, H., McEwan, J. K., Taylor, H., Oreffo, R., & Tare, R. (2017) · Biotechnology Journal · doi:10.1002/biot.201700070 · Cited by 11
Intact wound repair activity of human mesenchymal stem cells after YM155 mediated selective ablation of undifferentiated human embryonic stem cells
Kim, K.-T., Jeong, H., Kim, C., Kim, E., Heo, S.-H., Cho, S.-J., Hong, K., & Cha, H. (2017) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2017.01.011 · Cited by 10
Self-citation
Human Pluripotent Stem Cells and Derived Neuroprogenitors Display Differential Degrees of Susceptibility to BH3 Mimetics ABT-263, WEHI-539 and ABT-199
García, C. P., Videla-Richardson, G. A., Dimopoulos, N. A., Espinosa, D. D. F., Miriuka, S., Sevlever, G. E., Romorini, L., & Scassa, M. É. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152607 · Cited by 14
“In undifferentiated hESCs and hiPSCs there is a biased expression of many pro-apoptotic genes, against relatively fewer anti-apoptotic ones [16, 39].”
Background
Small Molecules
Lu, B., & Atala, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802225-2.00006-4 · Cited by 10
Beyond Vision: An Overview of Regenerative Medicine and Its Current Applications in Ophthalmological Care
Cruz-Pavlovich, F. J. S., Bolaños-Chang, A. J., Rio-Murillo, X. I. D., Aranda-Preciado, G. A., Razura-Ruiz, E. M., Santos, A., & Navarro‐Partida, J. (2024) · Cells · doi:10.3390/cells13020179 · Cited by 13
“It has been reported in mice that teratomas and other related tumors could develop secondarily to the use of pluripotent stem cell transplantation [10,12–14].”
Background
Optimizing Generation of Stem Cell-Derived Islet Cells
Verhoeff, K. K., Cuesta‐Gomez, N., Jasra, I. T., Marfil‐Garza, B. A., Dadheech, N., & Shapiro, A. M. J. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10391-3 · Cited by 11
“Inhibition of the pro-oncogene survivin with quercetin or YM155 has also demonstrated targeted iPSC cell death [70].”
Background
Screening of cytotoxic or cytostatic flavonoids with quantitative Fluorescent Ubiquitination-based Cell Cycle Indicator-based cell cycle assay
Go, Y., Lee, H.-J., Kong, H.-J., Jeong, H.-C., Lee, D.-Y., Hong, S.-K., Sung, S., Kwon, O.-S., & Cha, H.-J. (2018) · Royal Society Open Science · doi:10.1098/rsos.181303 · Cited by 10
Self-citation
Engineering cell fate: Spotlight on cell-activation and signaling-directed lineage conversion
Ebrahimi, B. (2016) · Tissue and Cell · doi:10.1016/j.tice.2016.07.005 · Cited by 12
Human-Induced Pluripotent Stem Cells (iPSCs) for Disease Modeling and Insulin Target Cell Regeneration in the Treatment of Insulin Resistance: A Review
Thiab, S., Azeez, J. M., Anala, A. D., Nanda, M., Khan, S., Butler, A. E., & Nandakumar, M. (2025) · Cells · doi:10.3390/cells14151188 · Cited by 10
Caffeic acid selectively eliminates teratogenic human-induced pluripotent stem cells via apoptotic cell death
Kim, A., Lee, S., & Chung, S. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154144 · Cited by 9
Self-citation
Application of Induced Pluripotent Stem Cells for Disease Modeling and 3D Model Construction: Focus on Osteoarthritis
Hwang, J. J., Choi, J., Rim, Y. A., Nam, Y., & Ju, J. H. (2021) · Cells · doi:10.3390/cells10113032 · Cited by 10
“Chemical treatments via quercetin/YM155 inducing the apoptosis of undifferentiated iPSCs have also emerged as an alternative solution [26,27].”
Background
Quantitative proteomics revealed extensive microenvironmental changes after stem cell transplantation in ischemic stroke
Chen, Y., Song, F., Tu, M., Wu, S., He, X., Liu, H., Xu, C.-Y., Zhang, K., Zhu, Y.-K., Zhou, R., et al. (2021) · Frontiers in Medicine · doi:10.1007/s11684-021-0842-9 · Cited by 9
“To the best of our knowledge, increasing evidence has indicated that tumor formation from iPSCs can be prevented by eliminating the remaining undifferentiated stem cells with small-molecules inhibitors [55,56], which should increase the safety of iPSCs-based therapy.”
Background
A technique for removing tumourigenic pluripotent stem cells using rBC2LCN lectin
Haramoto, Y., Onuma, Y., Mawaribuchi, S., Nakajima, Y., Aiki, Y., Higuchi, K., Shimizu, M., Tateno, H., Hirabayashi, J., & Ito, Y. (2020) · Regenerative Therapy · doi:10.1016/j.reth.2020.03.017 · Cited by 15
Preclinical Toxicity Studies for Regenerative Medicine in Japan.
Shigeto, J., Ichiki, T., Nii, T., Konno, K., Nakanishi, Y., & Sugiyama, D. (2018) · Clinical Therapeutics · doi:10.1016/j.clinthera.2018.09.007 · Cited by 9
Osteogenic prospective of deriving human dental stem cells in collagen matrix boost
Fang, T.-J., Wang, D.-H., Wang, C.-Y., Poongodi, R., Liou, N.-H., Liu, J.-C., Hsu, M.-L., Hong, P.-D., Yang, S.-F., & Liu, M.-L. (2017) · Journal of Materials Science: Materials in Medicine · doi:10.1007/s10856-017-6001-9 · Cited by 9
“used in clinical applications, it is critical to remove all residual pluripotent stem cells with teratoma potential [2].”
Background
Hypoimmunogenic pluripotent stem cells: A game-changer in cell-based regenerative medicine
Sarabi, P. A., Rismani, E., Shabanpouremam, M., Hendi, Z., Nikoubin, B., Rahimi, S., Taleb, M., Khosravi, A., Zarrabi, A., Hassan, M., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115134 · Cited by 7
Longitudinal analysis of genetic and epigenetic changes in human pluripotent stem cells in the landscape of culture-induced abnormality
Kim, Y., Kang, B., Kweon, S., Oh, S., Kim, D., Gil, D., Lee, H., Kim, J.-H., Ju, J. H., Roh, T.-Y., et al. (2024) · Experimental and Molecular Medicine · doi:10.1038/s12276-024-01334-8 · Cited by 8
“Since p53 is pivotal in inducing cell death in hPSCs 8,43 , p53 stabilization markedly promotes this outcome.”
Self-citation
Evaluating Strategies to Assess the Differentiation Potential of Human Pluripotent Stem Cells: A Review, Analysis and Call for Innovation
Smith, L. A., Quelch, R., Liu, F., Aguilar, A. H., & Przyborski, S. A. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-024-10793-5 · Cited by 10
“The success rate of a teratoma xenograft study may also provide information regarding the health of the PSCs tested, protocol success and assay utility, as well as insights into the developmental potential of PSC lineages which have been genetically manipulated [ 22, 33, 92, 93 ]).”
The Role of Induced Pluripotent Stem Cells in the Treatment of Stroke
Darban, Y. M., Askari, H., Ghasemi‐Kasman, M., Yavarpour‐Bali, H., Dehpanah, A., Gholizade, P., & Nosratiyan, N. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666240603084558 · Cited by 9
“Needs more specific vehicles for transplantation, which is broadly researched [42, 99].”
Real‐Time, Non‐Invasive Monitoring of Neuronal Differentiation Using Intein‐Enabled Fluorescence Signal Translocation in Genetically Encoded Stem Cell‐Based Biosensors
Lee, E., Choi, H. K., Kwon, Y., & Lee, K. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202400394 · Cited by 7
AT7867 promotes pancreatic progenitor differentiation of human iPSCs
Cuesta‐Gomez, N., Verhoeff, K. K., Dadheech, N., Pawlick, R. L., Marfil‐Garza, B. A., Razavy, H., & Shapiro, A. M. J. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.10.005 · Cited by 9
Selective elimination of human pluripotent stem cells by Anti-Dsg2 antibody-doxorubicin conjugates
Park, J., Lee, N. G., Oh, M., Song, J., Kim, W., Kwon, M., Kim, S. G., Han, B., Bae, K., Lee, D. G., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120265 · Cited by 13
Self-citation
Ethanol extract of Magnoliae cortex (EEMC) limits teratoma formation of pluripotent stem cells by selective elimination of undifferentiated cells through the p53-dependent mitochondrial apoptotic pathway
Kim, A., Lee, S., Seo, C., & Chung, S. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153198 · Cited by 10
Self-citation
Preclinical evaluation of patient-derived cells shows promise for Parkinson’s disease
Takahashi, J. B. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134031 · Cited by 13
Intrapancreatic Parenchymal Injection of Cells as a Useful Tool for Allowing a Small Number of Proliferative Cells to Grow In Vivo
Sato, M., Saitoh, I., Murakami, T., Kubota, N., Nakamura, S., Watanabe, S., & Inada, E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081678 · Cited by 8
Full biological characterization of human pluripotent stem cells will open the door to translational research
Kramer, N., Rosner, M., Kovačic, B., & Hengstschläger, M. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1763-2 · Cited by 10
Advanced in vitro Research Models to Study the Role of Endothelial Cells in Solid Organ Transplantation
Hullegie-Peelen, D. M., Hoogduijn, M. J., Hesselink, D. A., & Baan, C. C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.607953 · Cited by 8
“First, remaining undifferentiated hPSC within the organoids can transform into tumors/teratomas (167, 168).”
Background
Current State of Renal Regenerative Therapies
Shankar, A., Hoorn, E. J., Gribnau, J. H., Baan, C. C., & Hoogduijn, M. J. (2018) · Transplantation · doi:10.1097/tp.0000000000002547 · Cited by 8
“Currently, measures are being studied to improve genomic and epigenetic stability of PSCs, for example through the elimination of undifferentiated cells or the use of integration-free vectors.(98,107)”
Background
Newer Approaches to Identify Potential Untoward Effects in Functional Foods
Marone, P., Birkenbach, V. L., & Hayes, A. (2016) · International journal of toxicology · doi:10.1177/1091581815616781 · Cited by 7
“The most recent, exciting, and potentially controversial advances originate from various human stem cell lines including those induced from adult somatic stem cell lines cells through the introduction of specific transcription factors, and also from embryonic stem cells, to facilitate individual-based therapies.(125,1…”
Background
SSEA3 and Sialyl Lewis a Glycan Expression Is Controlled by B3GALT5 LTR through Lamin A-NFYA and SIRT1-STAT3 Signaling in Human ES Cells
Cai, B.-H., Lee, H.-Y., Chou, C., Wu, P.-H., Huang, H.-C., Chao, C.-C., Chung, H.-Y., & Kannagi, R. (2020) · Cells · doi:10.3390/cells9010177 · Cited by 6
“SSEA3 is a marker related to the depletion of non-reprogramming cells, which are derived from induced pluripotent stem cells [13], and SSEA3 and SSEA5 are also involved in the removal of undifferentiated or incompletely differentiated cells prior to transplantation to avoid teratoma formation [5,14].”
BackgroundSelf-citation
Chemical decontamination of iPS cell-derived neural cell mixtures
Mao, D., Chung, X. K. W., Andoh-Noda, T., Qin, Y., Sato, S., Takemoto, Y., Akamatsu, W., Okano, H., & Uesugi, M. (2018) · Chemical Communications · doi:10.1039/c7cc08686e · Cited by 7
Dioxonaphthoimidazoliums are Potent and Selective Rogue Stem Cell Clearing Agents with SOX2‐Suppressing Properties
Ho, S. S., Ali, A., Ng, Y.-C., Lam, K. K., Wang, S., Chan, W., Chin, T., & Go, M. (2016) · ChemMedChem · doi:10.1002/cmdc.201600262 · Cited by 6
Engineered Human Dental Pulp Stem Cells with Promising Potential for Regenerative Medicine
Inada, E., Saitoh, I., Terajima, M., Kiyokawa, Y., Kubota, N., Yamaza, H., Morohoshi, K., Nakamura, S., & Sato, M. (2025) · BioTech · doi:10.3390/biotech14040088 · Cited by 5
“…after differentiation induction using chemicals, i.e., N-oleoyl serinol (S18), a ceramide analog [194], quercetin and YM155, inhibitors of survival [195], antibodies, such as keratan sulfate glycan-recognizing antibody [196], or a thymidine kinase-based cell ablation system [197], before utilizing…”
Opportunities and impediments of human pluripotent stem cell-derived islets in the treatment of diabetes
Dadheech, N., Cuesta‐Gomez, N., Jasra, I. T., Verhoeff, K. K., Marfil‐Garza, B. A., Mouhammed, O., & Shapiro, A. M. J. (2022) · Journal of Immunology and Regenerative Medicine · doi:10.1016/j.regen.2022.100064 · Cited by 6
Salicylic diamines selectively eliminate residual undifferentiated cells from pluripotent stem cell-derived cardiomyocyte preparations
Burkert, K., Taheri, H., Hamad, S., Oliverio, M., Peinkofer, G., Kornfeld, J., Harnying, W., Pfannkuche, K., Hescheler, J., Berkessel, A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81351-z · Cited by 9
STB-HO, a novel mica fine particle, inhibits the teratoma-forming ability of human embryonic stem cells after in vivo transplantation
Choi, S. W., Shin, T., Uddin, M. H., Shin, J., Kang, T., Lee, B., Kim, H., Seo, Y., Shams, S., Jung, Y.-K., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6472 · Cited by 4
“Importantly, mitochondrial priming that exceeds the apoptotic threshold differs between PSCs and differentiated cells.”
BackgroundMethodInfluential
Engineered IRES-mediated promoter-free insulin-producing cells reverse hyperglycemia
Li, Y., Younis, D. A., He, C., Ni, C., Liu, R., Zhou, Y., Sun, Z., Lin, H., Xiao, Z., & Sun, B. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1439351 · Cited by 3
Epigenetic repression of CHCHD2 enhances survival from single cell dissociation through attenuated Rho A kinase activity
Kim, J., Kwon, E., Kim, Y.-J., Kim, D., Shin, Y.-Z., Gil, D., Kim, J., Shin, H. D., Kim, L. H., Lee, M., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05060-8 · Cited by 6
“In addition, when DNA damage occurs, cytoplasmic p53 stabilizes and moves into the mitochondria, increasing mitochondrial membrane permeability to induce swift apoptosis [7, 10].”
BackgroundMethodSelf-citation
Luteolin Induces Selective Cell Death of Human Pluripotent Stem Cells
Go, Y.-H., Kim, J., Jeong, H., Kim, S.-M., Kim, Y.-J., Park, S., Moon, S.-H., & Cha, H. (2020) · Biomedicines · doi:10.3390/biomedicines8110453 · Cited by 6
“Although a variety of stemotoxic small molecules such as YM155, a potent stemotoxic compound[9], of which the high effectiveness of teratoma inhibition [40,41] are examined, it would be still important to search for new stemotoxic small molecules to ensure the efficacy (toward undifferentiated hESCs and safety (toward…”
BackgroundMethodResultInfluentialSelf-citation
Electronic properties of a Weyl semimetal in crossed magnetic and electric fields
Алисултанов, З. З. (2017) · Journal of Experimental and Theoretical Physics · doi:10.1134/s1063776117110012 · Cited by 8
Nonclinical Studies for Cell-Based Medicines
Sharpe, M. E., Leoni, G., Barry, J., Schutte, R., & Mount, N. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-803115-5.00003-6 · Cited by 4
Implications of genetic and epigenetic aberrations to the tumorigenicity of human pluripotent stem cells
Keshet, G., Barbaric, I., & Benvenisty, N. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115743 · Cited by 4
The Potential of Induced Pluripotent Stem Cells to Advance the Treatment of Pancreatic Ductal Adenocarcinoma
Krog, R. T., de Miranda, N. F. C. C., Vahrmeijer, A. L., & Kooreman, N. G. (2021) · Cancers · doi:10.3390/cancers13225789 · Cited by 3
Helping Induced hPSCs Clean Up Their Act.
Jeong, H.-C., & Cha, H.-J. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.06.001 · Cited by 3
Self-citation
Improving the safety of iPSC-derived T cell therapy
Ando, M., Kinoshita, S., Furukawa, Y., Ando, J., Nakauchi, H., & Brenner, M. (2022) · Molecular Players in iPSC Technology · doi:10.1016/b978-0-323-90059-1.00010-5 · Cited by 3
Stem Cells to Inform the Neurobiology of Mental Illness
Johnstone, M., Hillary, R. F., & Clair, D. S. (2018) · Current topics in behavioral neurosciences · doi:10.1007/7854_2018_57 · Cited by 5
Recellularization of Kidney Scaffold With Stem Cells
Figliuzzi, M., Remuzzi, G., & Remuzzi, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801734-0.00063-1 · Cited by 6
Innovations in skeletal muscle regeneration: from physiology to bioengineering approaches for repair and restoration
Awad, K. R., Aguirre, J., Adegbite, M., Kumar, A. S., Yacoub, A. S., Xia, M., & Brotto, M. A. P. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1789642 · Cited by 3
“However, while enabling multilineage differentiation, any residual undifferentiated state of iPSCs poses a risk of teratoma (tumor) formation if transplanted in vivo ( Gutierrez-Aranda et al., 2010; Lee et al., 2013; Nelakanti et al., 2015).”
Selective Elimination of Genetic Variants of Human Embryonic Stem Cells from High Vulnerability to Ferroptosis
Kim, Y., Kim, S. M., Go, Y., Kim, H. S., Park, S., Kang, Y. P., & Cha, H.-J. (2024) · Biomaterials Research · doi:10.34133/bmr.0093 · Cited by 2
“Various strategies have been developed to prevent teratoma formation by residual undifferentiated hPSCs [ 2 , 3 ].”
Self-citation
Present and future of adult stem cells and induced pluripotent stem cells therapy for ischemic stroke
Bugallo-Casal, A., Pérez‐Mato, M., & Campos, F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822229-4.00014-0 · Cited by 3
Purification of Pluripotent Stem Cell-Derived Cardiomyocytes for Safe Cardiac Regeneration
Tohyama, S., & Fukuda, K. (2017) · Cardiac and vascular biology · doi:10.1007/978-3-319-56106-6_8 · Cited by 2
Cellular Engineering and Disease Modeling with Gene-Editing Nucleases
Osborn, M. J., & Tolar, J. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-3509-3_12 · Cited by 2
OCT3/4-Enhanced Dental Mesenchymal Stem Cells Acquire Hematopoietic Stem Cell–Like Properties and Support Hematopoietic Recovery in a Myelosuppressed Mouse Model
Han, J.-H., Lee, S.-Y., Jo, C.-H., Son, Y.-B., Lee, W.-J., Lee, H.-J., Hong, C.-Y., Park, S., Kang, S.-Y., Hwang, T.-S., et al. (2026) · Stem Cells and Development · doi:10.1177/15473287261452516 · Cited by 1
“8 Therefore, nontumorigenic and clinically compatible stem cell sources for HSC generation are needed.”
Self-citation
Cardiac regeneration: The present state and future direction of human pluripotent stem cell therapy
Umei, T. C., & Tohyama, S. (2026) · Journal of Cardiology · doi:10.1016/j.jjcc.2026.01.006 · Cited by 1
The cell replacement therapeutic potential of human pluripotent stem cells
Taei, A., Sajadi, F., Salahi, S., Enteshari, Z., Falah, N., Shiri, Z., Abasalizadeh, S., Hajizadeh‐Saffar, E., Hassani, S., & Baharvand, H. (2024) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2024.2443079 · Cited by 1
“Various studies have successfully eliminated hPSCs by inhibiting oleic acid synthesis, anti-apoptotic factors, and pore formation in the cell membrane [39,40].”
Generation of induced pluripotent stem cells from the Asian bats
Lee, Y., Koo, O., & Saadeldin, I. (2024) · International Journal of Veterinary Science and Medicine · doi:10.1080/23144599.2024.2384835 · Cited by 1

Authors: Lee, M.-O., Moon, S. H., Jeong, H.-C., Yi, J.-Y., Lee, T.-H., Shim, S. H., Rhee, Y.-H., Lee, S.-H., Oh, S.-J., Lee, M.-Y., Han, M.-J., Cho, Y. S., Chung, H.-M., Kim, K.-S., & Cha, H.-J.
Affiliations: Sogang University (KR)
CHA University (KR)
Sejong University (KR)
Hanyang University (KR)
Dongguk University (KR)
Harvard University (US)
Korea Research Institute of Bioscience and Biotechnology (KR)
Konkuk University (KR)
ORCID: Lee, Mi-Ok
Moon, Sung Hwan
Jeong, Ho-Chang
Lee, Tae-Hee
Shim, Sung Han
Lee, Sang-Hun
Lee, Moo-Yeol
Han, Min-Joon
Cho, Yee Sook
Chung, Hyung-Min
Kim, Kwang-Soo
Cha, Hyuk-Jin
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2013-08-05
Volume: 110
Issue: 35
Pages: E3281-90
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.1303669110
PMC: PMC3761568
OpenAlex: W2065594892
Cited by: 246
References: 68
Citations by year: 2026: 5 · 2025: 12 · 2024: 18 · 2023: 15 · 2022: 16 · 2021: 21 · 2020: 19 · 2019: 22 · 2018: 16 · 2017: 21 · 2016: 32 · 2015: 24 · 2014: 20 · 2013: 5
FWCI: 12.10
Type: journal article
Language: en
Open access: green
europepmc.org
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
KRIBB Repository (submittedVersion)
Seoul National University Open Repository (Seoul National University) (submittedVersion)
Funders: National Institute of Neurological Disorders and Stroke (R01NS070577, NS070577)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
Keywords: teratoma prevention, human pluripotent stem cells, human embryonic stem cells, human induced pluripotent stem cells, small molecule inhibitors, survivin, BCL10, quercetin, YM155, selective cell death, apoptosis, p53, dopaminergic neurons, smooth muscle cells
MeSH terms: B-Cell CLL-Lymphoma 10 Protein, Survivin, Cell Differentiation, Cells, Cultured, Humans, Imidazoles, Mitochondria, Naphthoquinones, Teratoma, Tumor Suppressor Protein p53, Apoptosis, Gene Expression Profiling, Stem Cell Transplantation, Pluripotent Stem Cells, Adaptor Proteins, Signal Transducing, Inhibitor of Apoptosis Proteins, Small Molecule Libraries

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inhibition of pluripotent stem cell-derived teratoma formation by small molecules

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Metadata

Record

About these checks